This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Mouse Anti-Canine Ornithine Decarboxylase (ODC) Monoclonal Antibody
Product Overview
BioVenic mouse monoclonal antibody is specific for canine ornithine decarboxylase. It can be applied to WB, ICC/IF and FACS assays of canine ornithine decarboxylase.
Specifications
Target Information
Canine ornithine decarboxylase (ODC) is a rate-limiting enzyme in the polyamine biosynthetic pathway, responsible for converting ornithine to putrescine, which initiates the synthesis of other polyamines critical for cell proliferation, cell-cell interaction, and cell cycle regulation. This enzyme plays diverse biological roles, including cell motility, stabilization of nucleic acids or membranes, regulation of ion channels and receptors, and affecting chromatin structure. In dogs, ODC is speculated to play a key role in several cancerous conditions, with ODC activity and polyamine levels increasing during specific phases in cancer cell lines compared to normal cells. As a therapeutic target, inhibiting ODC activity can help combat tumor growth, making it a significant target in canine oncology.
Shipping and Storage
This product is shipped with wet ice packs. Store at -20°C on receipt (up to 12 months). Avoid repeated freezing and thawing as this may denature the antibody.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.